Title for MeetingAbstracts
Alphabetical listing of titles
Competitive inhibition of HIV-1 expression by transactivation defective TAT genes.
Competitive inhibition of HIV-1 protease by 4-hydroxy- benzopyran-2-ones and by 4-hydroxy-6-phenyl-pyran-2-ones.
Competitive interference between a widely employed Calpha primer and Vbeta gene sequences in the RT-PCR-based semiquantitative analysis of the T-cell receptor repertoire.
Competitive reverse transcription-polymerase chain reaction for quantifying murine AIDS virus.
Competitive strategies in a regulated environment: the Israeli case.
Competitive Whole Virus Fitness Assay Using GFP Reporter Virus for Analysis of HIV-1 Isolates Free of Selective Drug Pressure.
Comphrensive dental service to the patients with HIV / AIDS.
Complacency, risk perception and the problem of HIV education.
Complement activation blocks the antigenicity of p41.
Complement activation by gp120-coated uninfected CD4+ T cells.
Complement activation by gp160 and complement-mediated enhancement of HIV infection of monocytic cell lines.
Complement activation in HIV infected patients with cryoglobulinemia.
Complement activation in HIV infection occurs through the classical pathway and reflects disease severity.
Complement allotypes and functional activity in HIV infection.
Complement and HIV-1 infection.
Complement deposition on the surface of HIV-infected cells mediates binding to cells carrying complement receptors.
Complement factor B allotypes and protein concentration patterns in HIV infection.
Complement levels and circulating immune complexes in a controlled, longitudinal, multicenter study on effects of intravenous immunoglobulin (IVIG) in adults with ARC/wr5.
Complement mediates HIV-1 infection of human cells in an antibody-independent fashion.
Complement Receptor Mediated Induction of Macrophage Apoptosis by S. pneumoniae.
Complement receptor type 2 (CR-2) is a receptor for in vitro complement-mediated, antibody-dependent enhancement (C'-ADE) of HIV-1 infection.
Complement receptor type 2 mediates infection of B lymphoblastoid cells by complement opsonized HIV.
Complement receptors CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of monocytes by complement-opsonized HIV independently of CD4.
Complement-enhanced HIV-1 binding to monocytes is dependent on alternative pathway activation, and mediated by complement receptors.
Complement-mediated antibody-dependent enhancement of HIV infection correlates to viral load and predicts progression of HIV disease.
Complement-mediated CD4-independent infection of human promonocytic cell lines with HIV-1 and HIV-2.
Complement-mediated neutralization of HIV requires activation of C5b-9 complex.
Complement-mediated, antibody-dependent enhancement of SIVmac239 infection in vitro.
Complementarities in the production of health: preventive health behaviors.
Complementary approaches in prevention: using homophobia and grief workshops for HIV-negative gay men.